Tokyo, July 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057887) titled 'The musculoskeletal function survey of HIV-infected middle-aged and elderly hemophilia(2025-2027)' on July 14.
Study Type:
Observational
Primary Sponsor:
Institute - Japan Institute for Health Security ,
National Center for Global Health and Medicine
Condition:
Condition - hemophilia
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to survey the motor function of HIV-infected hemophilia by cross-sectional and longitudinal compares.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 30
years-old
=
Gender - Male and Female
Key inclusion criteria - A case hoping for participation in the fitness test and agree to the study use of the result of range of motion, manual muscle test, a grip strength, the 10m walking test, and ADL questions and investigations(but the 10m walk test is not required.)
Key exclusion criteria - A case with not healing hemorrhagic arthropathy.
A case with joint bleeds.
A case with intramuscular bleeding.
Target Size - 75
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 14 Day
Date of IRB - 2025 Year 07 Month 14 Day
Anticipated trial start date - 2025 Year 07 Month 14 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066163
Disclaimer: Curated by HT Syndication.
